Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker LUNG
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Srikanth Radhakrishnan Chief Science & Techn. Officer | LUNG Pulmonx Corporation | Sale | 5,863 | $2.26 | $13.3K Sale | Form 4 ↗ |
| Sep 1, 2026 | Srikanth Radhakrishnan Chief Science & Techn. Officer | LUNG Pulmonx Corporation | Sale | 3,618 | $2.26 | $8,177 Sale | Form 4 ↗ |
| Sep 1, 2026 | Srikanth Radhakrishnan Chief Science & Techn. Officer | LUNG Pulmonx Corporation | Sale | 2,121 | $2.26 | $4,793 Sale | Form 4 ↗ |
| Sep 1, 2026 | Srikanth Radhakrishnan Chief Science & Techn. Officer | LUNG Pulmonx Corporation | Sale | 2,643 | $2.26 | $5,973 Sale | Form 4 ↗ |
| Sep 1, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 37,784 | $2.26 | $85.4K Sale | Form 4 ↗ |
| Sep 1, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 4,098 | $2.26 | $9,261 Sale | Form 4 ↗ |
| Sep 1, 2026 | Geoffrey Beran Rose Chief Commercial Officer | LUNG Pulmonx Corporation | Sale | 1,746 | $2.26 | $3,946 Sale | Form 4 ↗ |
| Sep 1, 2026 | Geoffrey Beran Rose Chief Commercial Officer | LUNG Pulmonx Corporation | Sale | 1,530 | $2.26 | $3,458 Sale | Form 4 ↗ |
| Sep 1, 2026 | Geoffrey Beran Rose Chief Commercial Officer | LUNG Pulmonx Corporation | Sale | 2,390 | $2.26 | $5,401 Sale | Form 4 ↗ |
| Sep 1, 2026 | Geoffrey Beran Rose Chief Commercial Officer | LUNG Pulmonx Corporation | Sale | 2,213 | $2.26 | $5,001 Sale | Form 4 ↗ |
| Sep 1, 2026 | David Aaron Lehman General Counsel | LUNG Pulmonx Corporation | Sale | 4,827 | $2.26 | $10.9K Sale | Form 4 ↗ |
| Sep 1, 2026 | David Aaron Lehman General Counsel | LUNG Pulmonx Corporation | Sale | 3,476 | $2.26 | $7,856 Sale | Form 4 ↗ |
| Sep 1, 2026 | David Aaron Lehman General Counsel | LUNG Pulmonx Corporation | Sale | 2,224 | $2.26 | $5,026 Sale | Form 4 ↗ |
| Sep 1, 2026 | David Aaron Lehman General Counsel | LUNG Pulmonx Corporation | Sale | 3,807 | $2.26 | $8,604 Sale | Form 4 ↗ |
| Jun 2, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 13,511 | $1.57 | $21.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 5,969 | $1.54 | $9,192 Sale | Form 4 ↗ |
| Jun 1, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 3,684 | $1.54 | $5,673 Sale | Form 4 ↗ |
| Jun 1, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 2,153 | $1.54 | $3,316 Sale | Form 4 ↗ |
| Jun 1, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 2,691 | $1.54 | $4,144 Sale | Form 4 ↗ |
| Jun 1, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 38,467 | $1.54 | $59.2K Sale | Form 4 ↗ |
| Jun 1, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 4,171 | $1.54 | $6,423 Sale | Form 4 ↗ |
| Jun 1, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 2,254 | $1.54 | $3,471 Sale | Form 4 ↗ |
| Jun 1, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 2,434 | $1.54 | $3,748 Sale | Form 4 ↗ |
| Jun 1, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 1,557 | $1.54 | $2,398 Sale | Form 4 ↗ |
| Jun 1, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 1,778 | $1.54 | $2,738 Sale | Form 4 ↗ |
| Jun 1, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 4,915 | $1.54 | $7,569 Sale | Form 4 ↗ |
| Jun 1, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 3,539 | $1.54 | $5,450 Sale | Form 4 ↗ |
| Jun 1, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 2,264 | $1.54 | $3,487 Sale | Form 4 ↗ |
| Jun 1, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 3,876 | $1.54 | $5,969 Sale | Form 4 ↗ |
| Mar 2, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 4,198 | $1.43 | $6,003 Sale | Form 4 ↗ |
| Mar 2, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 2,461 | $1.43 | $3,519 Sale | Form 4 ↗ |
| Mar 2, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 3,068 | $1.43 | $4,387 Sale | Form 4 ↗ |
| Mar 2, 2026 | Srikanth Radhakrishnan Chief Science &Techn. Officer | LUNG Pulmonx Corporation | Sale | 756 | $1.43 | $1,081 Sale | Form 4 ↗ |
| Mar 2, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 58,368 | $1.43 | $83.5K Sale | Form 4 ↗ |
| Mar 2, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 6,737 | $1.43 | $9,634 Sale | Form 4 ↗ |
| Mar 2, 2026 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 2,708 | $1.43 | $3,872 Sale | Form 4 ↗ |
| Mar 2, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 2,911 | $1.43 | $4,163 Sale | Form 4 ↗ |
| Mar 2, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 1,861 | $1.43 | $2,661 Sale | Form 4 ↗ |
| Mar 2, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 2,125 | $1.43 | $3,039 Sale | Form 4 ↗ |
| Mar 2, 2026 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 835 | $1.43 | $1,194 Sale | Form 4 ↗ |
| Mar 2, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 4,051 | $1.43 | $5,793 Sale | Form 4 ↗ |
| Mar 2, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 2,590 | $1.43 | $3,704 Sale | Form 4 ↗ |
| Mar 2, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 4,433 | $1.43 | $6,339 Sale | Form 4 ↗ |
| Mar 2, 2026 | David Aaron Lehman GENERAL COUNSEL | LUNG Pulmonx Corporation | Sale | 1,163 | $1.43 | $1,663 Sale | Form 4 ↗ |
| Dec 8, 2025 | Daniel P. Florin Director | LUNG Pulmonx Corporation | Sale | 23,321 | $1.99 | $46.4K Sale | Form 4 ↗ |
| Dec 1, 2025 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 6,281 | $1.57 | $9,861 Sale | Form 4 ↗ |
| Dec 1, 2025 | Glendon E. French III President and CEO, Director | LUNG Pulmonx Corporation | Sale | 2,524 | $1.57 | $3,963 Sale | Form 4 ↗ |
| Dec 1, 2025 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 2,379 | $1.57 | $3,735 Sale | Form 4 ↗ |
| Dec 1, 2025 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 1,522 | $1.57 | $2,390 Sale | Form 4 ↗ |
| Dec 1, 2025 | Geoffrey Beran Rose CHIEF COMMERCIAL OFFICER | LUNG Pulmonx Corporation | Sale | 1,738 | $1.57 | $2,729 Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:16 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances